Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
02 November 2020 | Story Ruan Bruwer | Photo Varsity Sports
Lefébre Rademan, the country’s top student netball player in 2019, has been snatched up by English netball club London Pulse to play in England in 2021.

 

Attempting to become an even better netballer, former Kovsies netball captain Lefébre Rademan decided to jet off to England to play in their league.

Rademan was contracted by London Pulse to compete in the European Superleague in 2021. She will be the fourth Kovsie after Maryka Holtzhausen (2015 and 2018-2019), Karla Pretorius (2016), and Khanyisa Chawane (2020) to play in the league.

Rademan said it was an easy decision, even though it will be far and a long time away from home. The league runs from February to July, with a pre-season in December. She will continue with her master’s degree at the University of the Free State next year.

“I am not going to play netball forever and such an opportunity doesn’t come often. Having competed against England, New Zealand, and Jamaica earlier in the year, I realised they play at a much higher level and if I want to improve and become the best, I would also need to move to a next level.”

“As a goal attack, having Protea teammate Sigi Burger (goal shooter) at the same club, will be an advantage for both of us and for the Proteas as a combination.”

Rademan has had a great past two years, making her Protea debut (12 tests in total) and receiving a number of accolades, such as the Varsity Netball Player of the Tournament in 2019.

In the Telkom Netball League in October, captaining the Free State Crinums, she was named Shooter of the Tournament. She was Player of the Match twice. Her goal average of 88,1% was the highest in the competition.

“Last year was such a good year for me personally, but that remains in the past. You can’t become complacent. I want to keep working hard and become a much better player,” Rademan said.

 

News Archive

Haemophilia home infusion workshop
2017-12-17


 Description: haemophilia Tags: Haemophilia, community, patient, clinical skills, training 

Parents receive training for homecare of their children with haemophilia.
Photo Supplied


Caregivers for haemophilia patients, and patients themselves from around the Free State and Northern Cape attended a home infusion workshop held by the Clinical Skills unit in the Faculty of Health Sciences in July 2017. “It felt liberating and I feel confident to give the factor to my son correctly,” said Amanda Chaba-Okeke, the mother of a young patient, at the workshop. Her son, also at the workshop, agreed. “It felt lovely and good to learn how to administer factor VIII.” 

Clinical skills to empower parents and communities

There were two concurrent sessions: one attended by doctors from the Haemophilia Treatment Centre, and the other attended by community members including factor VIII and XI recipients, caregivers and parents. The doctors’ meeting was shown informative videos and demonstrations on how to administer the newly devised factor VII and XI kit, and discussed the pressing need for trained nurses at local clinics. Dr Jaco Joubert, a haematologist, made an educational presentation to the community members.

The South African Haemophilia Foundation was represented by Mahlomola Sewolane, who gave a brief talk about the role of the organisation in relation to the condition. Meanwhile, procedural training in the simulation laboratory involved doctors and nurses helping participants to learn the procedures by using mannequins and even some volunteers from among the patients.

A medical condition causing serious complications
Haemophilia is a medical condition in which the ability of the blood to clot is severely impaired, even from a slight injury. The condition is typically caused by a hereditary lack of a coagulation factor, most often factor VIII. Usually patients must go through replacement therapy in which concentrates of clotting factor VIII (for haemophilia A) or clotting factor IX (for haemophilia B) are slowly dripped or injected into the vein, to help replace the clotting factor that is missing or low. Patients have to receive this treatment in hospital.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept